Caffesse Raul G, De La Rosa R M, De La Rosa G M, Weltman Robin
The University of Texas-Houston Dental Branch, Houston, Texas 77030, USA.
J Clin Periodontol. 2002 Feb;29(2):177-81. doi: 10.1034/j.1600-051x.2002.290213.x.
A genetic test for susceptibility of periodontal disease has been introduced. A positive test indicates a risk factor for more severe periodontal destruction. The prevalence of genotype positive subjects has been reported around 30%. In a Mexican population, we have found a 26% prevalence of genotype positive individuals. Few studies have reported the response to therapy in these individuals. The purpose of this study was to assess the response to mucogingival surgery in an otherwise periodontally healthy Hispanic population.
22 subjects (7 male and 15 female) with a mean age of 45 years participated. They were treated 3 years prior for the treatment of Types I and II recession defects using connective tissue grafts. No other active periodontal treatment was required, except for preventive maintenance. A full-mouth clinical evaluation was performed which included assessment of gingival inflammation and measurements of probing pocket depth and clinical attachment levels. Mean values per patient were determined. A finger stick blood sample was collected using specially provided DNA filter paper, let dried, and mailed for processing.
Results indicated that 5 out of the 22 subjects were genotype positive. The genotype positive subjects presented the following values: GI 1.13+/-0.17, PPD 2.48+/-0.46, and CAL 3.38+/-0.66. The values for the genotype negative subjects were GI 1.06+/-0.14, PPD 2.38+/-0.31 and CAL 3.11+/-0.53. No statistical significant differences were found when both groups were compared (p>0.05). Furthermore, the treatment of the localized recessions was effective and provided similar amount of coverage in genotype positive and negative subjects. However, more genotype negative subjects showed complete coverage of the recession than genotype positive individuals.
Within the limits of this study it is concluded that (1) periodontal health can be maintained with proper preventive maintenance irrespective of the genotype present, (2) the mean response to mucogingival surgery to cover localized gingival recessions is similar irrespective of the IL-1 periodontal genotype, however, full coverage is achieved more frequently in genotype negative subjects.
一种用于检测牙周病易感性的基因检测方法已被引入。检测呈阳性表明存在更严重牙周破坏的风险因素。据报道,基因型阳性受试者的患病率约为30%。在墨西哥人群中,我们发现基因型阳性个体的患病率为26%。很少有研究报道这些个体对治疗的反应。本研究的目的是评估在其他方面牙周健康的西班牙裔人群中对龈黏膜手术的反应。
22名受试者(7名男性和15名女性)参与研究,平均年龄45岁。他们在3年前接受了使用结缔组织移植治疗I型和II型牙龈退缩缺损的治疗。除预防性维护外,无需其他积极的牙周治疗。进行了全口临床评估,包括牙龈炎症评估以及探诊袋深度和临床附着水平的测量。确定了每位患者的平均值。使用专门提供的DNA滤纸采集手指血样,晾干后邮寄进行处理。
结果表明,22名受试者中有5名基因型呈阳性。基因型阳性受试者的数值如下:牙龈指数(GI)为1.13±0.17,探诊袋深度(PPD)为2.48±0.46,临床附着水平(CAL)为3.38±0.66。基因型阴性受试者的数值为:GI为1.06±0.14,PPD为2.38±0.31,CAL为3.11±0.53。两组比较时未发现统计学显著差异(p>0.05)。此外,局部牙龈退缩的治疗是有效的,并且在基因型阳性和阴性受试者中提供了相似的覆盖量。然而,基因型阴性受试者比基因型阳性个体更多地显示出牙龈退缩的完全覆盖。
在本研究的范围内得出以下结论:(1)无论存在何种基因型,可以通过适当的预防性维护来维持牙周健康;(2)无论IL-1牙周基因型如何,覆盖局部牙龈退缩的龈黏膜手术的平均反应相似,然而,基因型阴性受试者更频繁地实现完全覆盖。